Morphosis Limited 11341623 false 2022-06-01 2023-05-31 2023-05-31 The principal activity of the company is Management Consultancy Digita Accounts Production Advanced 6.30.9574.0 true true 11341623 2022-06-01 2023-05-31 11341623 2023-05-31 11341623 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2023-05-31 11341623 core:RetainedEarningsAccumulatedLosses 2023-05-31 11341623 core:ShareCapital 2023-05-31 11341623 core:CurrentFinancialInstruments 2023-05-31 11341623 core:CurrentFinancialInstruments core:WithinOneYear 2023-05-31 11341623 core:FurnitureFittingsToolsEquipment 2023-05-31 11341623 bus:SmallEntities 2022-06-01 2023-05-31 11341623 bus:AuditExemptWithAccountantsReport 2022-06-01 2023-05-31 11341623 bus:FullAccounts 2022-06-01 2023-05-31 11341623 bus:SmallCompaniesRegimeForAccounts 2022-06-01 2023-05-31 11341623 bus:RegisteredOffice 2022-06-01 2023-05-31 11341623 bus:Director1 2022-06-01 2023-05-31 11341623 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2022-06-01 2023-05-31 11341623 bus:PrivateLimitedCompanyLtd 2022-06-01 2023-05-31 11341623 core:FurnitureFittings 2022-06-01 2023-05-31 11341623 core:FurnitureFittingsToolsEquipment 2022-06-01 2023-05-31 11341623 core:OfficeEquipment 2022-06-01 2023-05-31 11341623 countries:England 2022-06-01 2023-05-31 11341623 2022-05-31 11341623 core:FurnitureFittingsToolsEquipment 2022-05-31 11341623 2021-06-01 2022-05-31 11341623 2022-05-31 11341623 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2022-05-31 11341623 core:RetainedEarningsAccumulatedLosses 2022-05-31 11341623 core:ShareCapital 2022-05-31 11341623 core:CurrentFinancialInstruments 2022-05-31 11341623 core:CurrentFinancialInstruments core:WithinOneYear 2022-05-31 11341623 core:FurnitureFittingsToolsEquipment 2022-05-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 11341623

Morphosis Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 May 2023

 

Morphosis Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 5

 

Morphosis Limited

Company Information

Director

Mrs Winnie Yi-Chen Palmer

Registered office

Brookfield Court, Selby Road
Leeds
West Yorkshire
LS25 1NB

Accountants

Clever Accounts Ltd
Brookfield Court
Selby Road
Garforth, Leeds
LS25 1NB

 

Morphosis Limited

(Registration number: 11341623)
Balance Sheet as at 31 May 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

141

568

Current assets

 

Debtors

176

176

Investments

5

70,275

70,275

Cash at bank and in hand

 

7,715

14,890

 

78,166

85,341

Creditors: Amounts falling due within one year

(3,767)

(5,478)

Net current assets

 

74,399

79,863

Net assets

 

74,540

80,431

Capital and reserves

 

Called up share capital

6

1

1

Retained earnings

74,539

80,430

Shareholders' funds

 

74,540

80,431

For the financial year ending 31 May 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 14 February 2024
 

.........................................

Mrs Winnie Yi-Chen Palmer
Director

 

Morphosis Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2023

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Brookfield Court, Selby Road
Leeds
West Yorkshire
LS25 1NB

These financial statements were authorised for issue by the director on 14 February 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

 

Morphosis Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2023

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture & Fittings

33% Reducing Balance

Office equipment

3 Year Straight Line

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Morphosis Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2023

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 June 2022

2,117

2,117

At 31 May 2023

2,117

2,117

Depreciation

At 1 June 2022

1,549

1,549

Charge for the year

427

427

At 31 May 2023

1,976

1,976

Carrying amount

At 31 May 2023

141

141

At 31 May 2022

568

568

5

Current asset investments

2023
£

2022
£

Other investments

70,275

70,275

6

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary Shares of £1 each

1

1

1

1